These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33723319)
1. Wnt5A modulates integrin expression in a receptor-dependent manner in ovarian cancer cells. Azimian-Zavareh V; Dehghani-Ghobadi Z; Ebrahimi M; Mirzazadeh K; Nazarenko I; Hossein G Sci Rep; 2021 Mar; 11(1):5885. PubMed ID: 33723319 [TBL] [Abstract][Full Text] [Related]
2. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation. Dehghani-Ghobadi Z; Sheikh Hasani S; Arefian E; Hossein G Cells; 2022 Jan; 11(2):. PubMed ID: 35053353 [TBL] [Abstract][Full Text] [Related]
3. Wnt5a influences viability, migration, adhesion, colony formation, E- and N-cadherin expression of human ovarian cancer cell line SKOV-3. Jannesari-Ladani F; Hossein G; Monhasery N; Shahoei SH; Izadi Mood N Folia Biol (Praha); 2014; 60(2):57-67. PubMed ID: 24785108 [TBL] [Abstract][Full Text] [Related]
4. Differential Wnt11 expression related to Wnt5a in high- and low-grade serous ovarian cancer: implications for migration, adhesion and survival. Jannesari-Ladani F; Hossein G; Izadi-Mood N Asian Pac J Cancer Prev; 2014; 15(3):1489-95. PubMed ID: 24606488 [TBL] [Abstract][Full Text] [Related]
5. Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Dong Y; Tan OL; Loessner D; Stephens C; Walpole C; Boyle GM; Parsons PG; Clements JA Cancer Res; 2010 Apr; 70(7):2624-33. PubMed ID: 20332224 [TBL] [Abstract][Full Text] [Related]
6. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3. Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612 [TBL] [Abstract][Full Text] [Related]
7. Wnt5A regulates the expression of ROR2 tyrosine kinase receptor in ovarian cancer cells. Hossein G; Arabzadeh S; Salehi-Dulabi Z; Dehghani-Ghobadi Z; Heidarian Y; Talebi-Juybari M Biochem Cell Biol; 2017 Dec; 95(6):609-615. PubMed ID: 28538104 [TBL] [Abstract][Full Text] [Related]
8. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655 [TBL] [Abstract][Full Text] [Related]
9. ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer. Grither WR; Baker B; Morikis VA; Ilagan MXG; Fuh KC; Longmore GD Mol Cancer Res; 2024 May; 22(5):495-507. PubMed ID: 38334461 [TBL] [Abstract][Full Text] [Related]
10. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Ahmed N; Riley C; Rice G; Quinn M Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482 [TBL] [Abstract][Full Text] [Related]
11. Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis. Azimian-Zavareh V; Hossein G; Ebrahimi M; Dehghani-Ghobadi Z Exp Cell Res; 2018 Aug; 369(1):90-104. PubMed ID: 29753625 [TBL] [Abstract][Full Text] [Related]
12. Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis. Asem M; Young AM; Oyama C; Claure De La Zerda A; Liu Y; Yang J; Hilliard TS; Johnson J; Harper EI; Guldner I; Zhang S; Page-Mayberry T; Kaliney WJ; Stack MS Cancer Res; 2020 Mar; 80(5):1156-1170. PubMed ID: 31932454 [TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3. Basu M; Roy SS J Biol Chem; 2013 Feb; 288(6):4355-67. PubMed ID: 23250740 [TBL] [Abstract][Full Text] [Related]
14. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Cannistra SA; Ottensmeier C; Niloff J; Orta B; DiCarlo J Gynecol Oncol; 1995 Aug; 58(2):216-25. PubMed ID: 7542622 [TBL] [Abstract][Full Text] [Related]
15. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598 [TBL] [Abstract][Full Text] [Related]
16. Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of beta1 integrin. Klausen C; Leung PC; Auersperg N Mol Cancer Res; 2009 Sep; 7(9):1425-37. PubMed ID: 19723874 [TBL] [Abstract][Full Text] [Related]
17. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition. Prasad CP; Chaurasiya SK; Guilmain W; Andersson T J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766 [TBL] [Abstract][Full Text] [Related]
19. Wnt5a: A promising therapeutic target in ovarian cancer. Zhou W; Mei J; Gu D; Xu J; Wang R; Wang H; Liu C Pathol Res Pract; 2021 Mar; 219():153348. PubMed ID: 33540373 [TBL] [Abstract][Full Text] [Related]
20. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis. Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]